| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
1 Signaling and Development Laboratory, Marie Curie Research Institute, Surrey, United Kingdom and 2 Department of Molecular Biology, Medical University of Innsbruck, Innsbruck, Austria
Requests for reprints: Colin R. Goding, Signalling and Development Laboratory, Marie Curie Research Institute, The Chart, Oxted, Surrey RH8 OTL, United Kingdom. Phone: 44-1883-722306; Fax: 44-1883-714375; E-mail: c.goding{at}mcri.ac.uk.
The INK4a and ARF genes found at the CDKN2A locus are key effectors of cellular senescence that is believed to act as a powerful anticancer mechanism. Accordingly, mutations in these genes are present in a wide variety of spontaneous human cancers and CDKN2A germ line mutations are found in familial melanoma. The TBX2 gene encoding a key developmental transcription factor is amplified in pancreatic cancer cell lines and preferentially amplified and overexpressed in BRCA1 and BRCA2 mutated breast tumors. Overexpression of Tbx2 and the related factor Tbx3, which is also overexpressed in breast cancer and melanomas, can suppress senescence in defined experimental systems through repression of ARF expression. However, it is not known how Tbx2 mediates its repressive effect nor whether endogenous Tbx2 or Tbx3 perform a similar antisenescence function in transformed cells. This is a particularly important question because the loss of CDKN2A in many human cancers would, in principle, bypass the requirement for Tbx2/3-mediated repression of ARF in suppressing senescence. We show here that Tbx2 is overexpressed in melanoma cell lines and that Tbx2 targets histone deacetylase 1 to the p21Cip1 (CDKN1A) initiator. Strikingly, expression of an inducible dominant-negative Tbx2 (dnTbx2) leads to displacement of histone deacetylase 1, up-regulation of p21Cip1 expression, and the induction of replicative senescence in CDKN2A-null B16 melanoma cells. In human melanoma cells, expression of dnTbx2 leads to severely reduced growth and induction of senescence-associated heterochromatin foci. The results suggest that the activity of endogenous Tbx2 is critically required to maintain proliferation and suppress senescence in melanomas.
Key Words: Tbx2 • senescence • HDAC1 • melanoma • CDKN2A
This article has been cited by other articles:
|
|
 |
|
  M. Rodriguez, E. Aladowicz, L. Lanfrancone, and C. R. Goding Tbx3 Represses E-Cadherin Expression and Enhances Melanoma Invasiveness Cancer Res., October 1, 2008; 68(19): 7872 - 7881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yarosh, T. Barrientos, T. Esmailpour, L. Lin, P. M. Carpenter, K. Osann, H. Anton-Culver, and T. Huang TBX3 Is Overexpressed in Breast Cancer and Represses p14ARF by Interacting with Histone Deacetylases Cancer Res., February 1, 2008; 68(3): 693 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Abrahams, S. Mowla, M. I. Parker, C. R. Goding, and S. Prince UV-mediated Regulation of the Anti-senescence Factor Tbx2 J. Biol. Chem., January 25, 2008; 283(4): 2223 - 2230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. F. Farin, M. Bussen, M. K. Schmidt, M. K. Singh, K. Schuster-Gossler, and A. Kispert Transcriptional Repression by the T-box Proteins Tbx18 and Tbx15 Depends on Groucho Corepressors J. Biol. Chem., August 31, 2007; 282(35): 25748 - 25759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Senese, K. Zaragoza, S. Minardi, I. Muradore, S. Ronzoni, A. Passafaro, L. Bernard, G. F. Draetta, M. Alcalay, C. Seiser, et al. Role for Histone Deacetylase 1 in Human Tumor Cell Proliferation Mol. Cell. Biol., July 1, 2007; 27(13): 4784 - 4795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Carreira, J. Goodall, L. Denat, M. Rodriguez, P. Nuciforo, K. S. Hoek, A. Testori, L. Larue, and C. R. Goding Mitf regulation of Dia1 controls melanoma proliferation and invasiveness Genes & Dev., December 15, 2006; 20(24): 3426 - 3439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schepsky, K. Bruser, G. J. Gunnarsson, J. Goodall, J. H. Hallsson, C. R. Goding, E. Steingrimsson, and A. Hecht The Microphthalmia-Associated Transcription Factor Mitf Interacts with {beta}-Catenin To Determine Target Gene Expression Mol. Cell. Biol., December 1, 2006; 26(23): 8914 - 8927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Dobrzycka, K. Kang, S. Jiang, R. Meyer, P. H. Rao, A. V. Lee, and S. Oesterreich Disruption of Scaffold Attachment Factor B1 Leads to TBX2 Up-regulation, Lack of p19ARF Induction, Lack of Senescence, and Cell Immortalization Cancer Res., August 15, 2006; 66(16): 7859 - 7863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Petti, A. Molla, C. Vegetti, S. Ferrone, A. Anichini, and M. Sensi Coexpression of NRASQ61R and BRAFV600E in Human Melanoma Cells Activates Senescence and Increases Susceptibility to Cell-Mediated Cytotoxicity. Cancer Res., July 1, 2006; 66(13): 6503 - 6511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Braig and C. A. Schmitt Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res., March 15, 2006; 66(6): 2881 - 2884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Stennard and R. P. Harvey T-box transcription factors and their roles in regulatory hierarchies in the developing heart Development, November 15, 2005; 132(22): 4897 - 4910. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
